# Laser and Medical Treatment of Diabetic Macular Edema

> **NCT00050479** · PHASE3 · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 100 (—)

## Conditions studied

- Macular Degeneration

## Interventions

- **DRUG:** Celecoxib (Celebrex)

## Key facts

- **NCT ID:** NCT00050479
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** —
- **Final completion:** 2006-07
- **Target enrollment:** 100 (—)
- **Last updated:** 2006-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00050479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00050479, "Laser and Medical Treatment of Diabetic Macular Edema". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00050479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
